• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向调节性T细胞用于黑色素瘤的免疫治疗。

Targeting regulatory T cells for immunotherapy in melanoma.

作者信息

Huang Lili, Guo Yeye, Liu Shujing, Wang Huaishan, Zhu Jinjin, Ou Lingling, Xu Xiaowei

机构信息

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 USA.

出版信息

Mol Biomed. 2021;2(1):11. doi: 10.1186/s43556-021-00038-z. Epub 2021 Apr 19.

DOI:10.1186/s43556-021-00038-z
PMID:34806028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8591697/
Abstract

Regulatory T cells (Tregs) are essential in the maintenance of immunity, and they are also a key to immune suppressive microenvironment in solid tumors. Many studies have revealed the biology of Tregs in various human pathologies. Here we review recent understandings of the immunophenotypes and suppressive functions of Tregs in melanoma, including Treg recruitment and expansion in a tumor. Tregs are frequently accumulated in melanoma and the ratio of CD8 T cells versus Tregs in the melanoma is predictive for patient survival. Hence, depletion of Tregs is a promising strategy for the enhancement of anti-melanoma immunity. Many recent studies are aimed to target Tregs in melanoma. Distinguishing Tregs from other immune cells and understanding the function of different subsets of Tregs may contribute to better therapeutic efficacy. Depletion of functional Tregs from the tumor microenvironment has been tested to induce clinically relevant immune responses against melanomas. However, the lack of Treg specific therapeutic antibodies or Treg specific depleting strategies is a big hurdle that is yet to be overcome. Additional studies to fine-tune currently available therapies and more agents that specifically and selectively target tumor infiltrating Tregs in melanoma are urgently needed.

摘要

调节性T细胞(Tregs)对维持免疫至关重要,也是实体瘤免疫抑制微环境的关键。许多研究揭示了Tregs在各种人类疾病中的生物学特性。在此,我们综述了黑色素瘤中Tregs免疫表型和抑制功能的最新认识,包括Tregs在肿瘤中的募集和扩增。Tregs在黑色素瘤中常积聚,黑色素瘤中CD8 T细胞与Tregs的比例可预测患者生存。因此,耗竭Tregs是增强抗黑色素瘤免疫力的一种有前景的策略。最近许多研究旨在靶向黑色素瘤中的Tregs。区分Tregs与其他免疫细胞并了解不同亚群Tregs的功能可能有助于提高治疗效果。已测试从肿瘤微环境中耗竭功能性Tregs以诱导针对黑色素瘤的临床相关免疫反应。然而,缺乏Treg特异性治疗抗体或Treg特异性耗竭策略是一个尚未克服的重大障碍。迫切需要进一步研究来微调现有疗法,并研发更多特异性和选择性靶向黑色素瘤中肿瘤浸润Tregs的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/f845405c74e3/43556_2021_38_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/7e57df1b1308/43556_2021_38_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/8db11712fb12/43556_2021_38_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/f47e277efd18/43556_2021_38_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/f845405c74e3/43556_2021_38_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/7e57df1b1308/43556_2021_38_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/8db11712fb12/43556_2021_38_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/f47e277efd18/43556_2021_38_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f652/8607391/f845405c74e3/43556_2021_38_Fig4_HTML.jpg

相似文献

1
Targeting regulatory T cells for immunotherapy in melanoma.靶向调节性T细胞用于黑色素瘤的免疫治疗。
Mol Biomed. 2021;2(1):11. doi: 10.1186/s43556-021-00038-z. Epub 2021 Apr 19.
2
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?黑色素瘤中的调节性 T 细胞:迈向有效免疫治疗的最后一道难关?
Lancet Oncol. 2012 Jan;13(1):e32-42. doi: 10.1016/S1470-2045(11)70155-3.
3
Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.在小鼠黑色素瘤模型中,使用靶向CD25的光动力疗法对调节性T细胞进行瘤内清除可诱导抗肿瘤免疫反应。
Oncotarget. 2017 Jul 18;8(29):47440-47453. doi: 10.18632/oncotarget.17663.
4
Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.肿瘤内干细胞样 CCR4+ 调节性 T 细胞协调乙型肝炎相关 HCC 的免疫抑制微环境。
J Hepatol. 2022 Jan;76(1):148-159. doi: 10.1016/j.jhep.2021.08.029. Epub 2021 Sep 12.
5
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody.CCR8 在肿瘤组织与正常组织中的差异表达可使新型 Fc 优化抗 CCR8 抗体 GS-1811 特异性耗尽肿瘤浸润性调节性 T 细胞。
Oncoimmunology. 2022 Nov 4;11(1):2141007. doi: 10.1080/2162402X.2022.2141007. eCollection 2022.
6
Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy.肿瘤微环境中的调节性T细胞与抗癌免疫治疗方法
Immune Netw. 2020 Feb 11;20(1):e4. doi: 10.4110/in.2020.20.e4. eCollection 2020 Feb.
7
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.激动剂抗 GITR 单克隆抗体通过改变调节性 T 细胞的稳定性和肿瘤内蓄积,诱导小鼠黑色素瘤肿瘤免疫。
PLoS One. 2010 May 3;5(5):e10436. doi: 10.1371/journal.pone.0010436.
8
Roles of regulatory T cells in cancer immunity.调节性T细胞在癌症免疫中的作用。
Int Immunol. 2016 Aug;28(8):401-9. doi: 10.1093/intimm/dxw025. Epub 2016 May 9.
9
Regulatory T cells in the immunotherapy of melanoma.调节性T细胞在黑色素瘤免疫治疗中的作用
Tumour Biol. 2016 Jan;37(1):77-85. doi: 10.1007/s13277-015-4315-0. Epub 2015 Oct 30.
10
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.使用AZD8701(一种新型反义寡核苷酸)直接靶向调节性T细胞中的FOXP3,以缓解癌症中的免疫抑制。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-003892.

引用本文的文献

1
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.用于增强免疫检查点抑制剂治疗黑色素瘤疗效的表观遗传修饰剂。
Transl Oncol. 2025 Jun 23;59:102452. doi: 10.1016/j.tranon.2025.102452.
2
The Role of Tregs in the Tumor Microenvironment.调节性T细胞在肿瘤微环境中的作用。
Biomedicines. 2025 May 11;13(5):1173. doi: 10.3390/biomedicines13051173.
3
Immunomodulatory effects of intratumoral cowpea mosaic virus and calreticulin nanoparticles in canine tumors: early results.肿瘤内豇豆花叶病毒和钙网蛋白纳米颗粒对犬类肿瘤的免疫调节作用:早期结果

本文引用的文献

1
Tyrosine kinase inhibitors modulate dendritic cell activity via confining c-Kit signaling and tryptophan metabolism.酪氨酸激酶抑制剂通过限制c-Kit信号传导和色氨酸代谢来调节树突状细胞活性。
Int Immunopharmacol. 2020 Mar 6;82:106357. doi: 10.1016/j.intimp.2020.106357.
2
PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.黑色素瘤中的程序性死亡受体配体1(PD-L1)、程序性死亡受体1(PD-1)、淋巴细胞激活基因3(LAG-3)和T细胞免疫球蛋白黏蛋白-3(TIM-3):脑转移灶与相应颅外肿瘤的表达比较
Cureus. 2019 Dec 11;11(12):e6352. doi: 10.7759/cureus.6352.
3
Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells.
Front Immunol. 2025 May 2;16:1566394. doi: 10.3389/fimmu.2025.1566394. eCollection 2025.
4
SPRY1 regulates macrophage M1 polarization in skin aging and melanoma prognosis.SPRY1在皮肤衰老和黑色素瘤预后中调节巨噬细胞M1极化。
Transl Oncol. 2025 Apr;54:102331. doi: 10.1016/j.tranon.2025.102331. Epub 2025 Feb 28.
5
Progress in personalized immunotherapy for patients with brain metastasis.脑转移患者个性化免疫治疗的进展。
NPJ Precis Oncol. 2025 Jan 29;9(1):31. doi: 10.1038/s41698-025-00812-0.
6
E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness.E2F1 诱导的自分泌 IL-6 炎症环介导了癌症-免疫串扰,预测了 T 细胞表型转换和治疗反应性。
Front Immunol. 2024 Oct 31;15:1470368. doi: 10.3389/fimmu.2024.1470368. eCollection 2024.
7
Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy.树突状细胞内源性 PTPN22 负调控抗肿瘤免疫,并影响抗 PD-L1 疗效。
J Immunother Cancer. 2024 Oct 26;12(10):e009588. doi: 10.1136/jitc-2024-009588.
8
Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.调节性 T 细胞治疗乳腺癌的策略:整体到局部方面。
Cells. 2024 Sep 11;13(18):1526. doi: 10.3390/cells13181526.
9
Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.靶向 FOXP3+Tregs 以增强抗肿瘤免疫。
Front Immunol. 2024 Aug 21;15:1426657. doi: 10.3389/fimmu.2024.1426657. eCollection 2024.
10
Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy.肺癌中的糖皮质激素:把握免疫抑制与治疗效果之间的平衡。
Heliyon. 2024 Jun 4;10(12):e32357. doi: 10.1016/j.heliyon.2024.e32357. eCollection 2024 Jun 30.
黑色素瘤患者血浆中的黑色素瘤细胞衍生的外泌体抑制免疫效应细胞的功能。
Sci Rep. 2020 Jan 9;10(1):92. doi: 10.1038/s41598-019-56542-4.
4
Tumor-derived CCL20 affects B16 melanoma growth in mice.肿瘤来源的 CCL20 影响小鼠 B16 黑色素瘤的生长。
J Dermatol Sci. 2020 Jan;97(1):57-65. doi: 10.1016/j.jdermsci.2019.12.005. Epub 2019 Dec 13.
5
Regulatory T Cells Induce Metastasis by Increasing Tgf-β and Enhancing the Epithelial–Mesenchymal Transition.调节性 T 细胞通过增加 TGF-β并增强上皮-间充质转化来促进转移。
Cells. 2019 Nov 4;8(11):1387. doi: 10.3390/cells8111387.
6
The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy.PD-1/PD-L1轴在调节性T细胞发育和功能中的作用:对癌症免疫治疗的启示
Onco Targets Ther. 2019 Oct 15;12:8437-8445. doi: 10.2147/OTT.S221340. eCollection 2019.
7
Promotion effects of mono-2-ethyhexyl phthalate (MEHP) on migration and invasion of human melanoma cells via activation of TGF-β signals.邻苯二甲酸二(2-乙基己基)酯(MEHP)通过激活 TGF-β 信号促进人黑色素瘤细胞的迁移和侵袭。
Cell Biochem Funct. 2020 Jan;38(1):38-46. doi: 10.1002/cbf.3447. Epub 2019 Oct 30.
8
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.靶向 CXCR4 增强抗 PD-1 疗效,改变肿瘤微环境并抑制肿瘤 PD-1。
J Exp Clin Cancer Res. 2019 Oct 28;38(1):432. doi: 10.1186/s13046-019-1420-8.
9
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.持续的 I 型干扰素信号作为对 PD-1 阻断耐药的机制。
Cell Res. 2019 Oct;29(10):846-861. doi: 10.1038/s41422-019-0224-x. Epub 2019 Sep 3.
10
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.Neuropilin-1 调控抗肿瘤 CD8 T 细胞免疫及检查点阻断免疫治疗。
Nat Commun. 2019 Jul 26;10(1):3345. doi: 10.1038/s41467-019-11280-z.